General anesthesia: Patients will receive general anesthesia.
Bupivacaine 0.5%: Patients will receive general anesthesia and erector spinae plane block.
Bupivacaine 0.5%: Patients will receive general anesthesia and erector spinae plane block with pericapsular nerve block.
Study summary
This study will be conducted to evaluate the effect of pericapsular nerve group and erector spinae plane block as adjuvants to general anesthesia in geriatrics undergoing total hip arthroplasty.
Eligibility
Sex
ALL
Min age
75 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* Aged \>75 years.
* Both sexes.
* American Society of Anesthesiologists (ASA) classification I-III.
* Undergoing total hip arthroplasty under general anesthesia.
Exclusion Criteria:
* Patient refusal.
* Body mass index (BMI) \> 30 kg/m2.
* Allergy to local anesthesia drugs.
* Infection at the site of intervention.
* Coagulopathies.
* Preexisting advanced diseases of the kidney or liver.
Primary outcome measure(s)
Mean sevoflurane MAC to achieve bispectral index (BIS) values (45-55) — Intraoperatively Sevoflurane will be adjusted to maintain a steady state with a BIS value in the range of 45-55 and will be fixed through the study period
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.